pharmaceuticals-and-healthcare

China Human Vaccine Market Research Report 2018


Published On : Sep 2018

Category : Pharmaceutical

No. of Pages : 145 pages

  • $3200
  • $6400

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
In the last several years, the market of China Human Vaccine changed greatly, with an average growth rate of -2.72% during 2013 to 2017. In 2017, revenue of China Human Vaccine is nearly 2478.15 M USD; the actual sale is about 552 M Dose.

The major players in China market include
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech


Geographically, this report splits the China market into six regions,
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China


On the basis of product, the Human Vaccine market is primarily split into
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Rota vaccine
Other


On the basis on the end users/applications, this report covers
Adults
Children


In the recent times, the global market for China human vaccine market research report 2018 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of China human vaccine market research report 2018 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the China human vaccine market research report 2018 production processes, which is also reflecting positively on the growth of this market.

The research report on the China human vaccine market research report 2018 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of China human vaccine market research report 2018 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for China human vaccine market research report 2018, including the definition, classification, and industry chain structure of China human vaccine market research report 2018, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the China human vaccine market research report 2018.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for China human vaccine market research report 2018 in details. It provides in-depth information on the development trends and the policies and regulations, concerning China human vaccine market research report 2018, implemented in each of the geographical segments. The predominant applications of the China human vaccine market research report 2018 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for China human vaccine market research report 2018 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the China human vaccine market research report 2018 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of Human Vaccine1
Table China Human Vaccine Sales (M Dose) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)2
Figure China Human Vaccine Sales Volume Market Share by Types in 20173
Figure Product Picture of Varicella4
Figure Product Picture of Influenza4
Figure Product Picture of Polio5
Figure Product Picture of Hepatitis A5
Figure Product Picture of Rabies6
Figure Product Picture of BCG6
Figure Product Picture of Hepatitis B7
Figure Product Picture of Pertussis7
Figure Product Picture of Pneumococcal8
Figure Rota Vaccine Product Picture8
Table China Human Vaccine Sales (M Dose) Comparison by Applications (2013-2025)9
Figure China Sales Market Share (%) of Human Vaccine by Applications in 20179
Figure Adults Examples10
Figure Children Examples10
Table China Human Vaccine Market Size (M USD) Comparison by Region (2013-2025)11
Figure South China Human Vaccine Revenue (M USD) and Growth Rate (2013-2025)12
Figure East China Human Vaccine Revenue (M USD) and Growth Rate (2013-2025)13
Figure Southwest China Human Vaccine Revenue (M USD) and Growth Rate (2013-2025)14
Figure Northeast China Human Vaccine Revenue (M USD) and Growth Rate (2013-2025)15
Figure North China Human Vaccine Revenue (M USD) and Growth Rate (2013-2025)16
Figure Central China Human Vaccine Revenue (M USD) and Growth Rate (2013-2025)17
Figure Northwest China Human Vaccine Revenue (M USD) and Growth Rate (2013-2025)18
Figure China Human Vaccine Sales (M Dose) and Growth Rate (%) (2013-2025)19
Figure China Human Vaccine Revenue (M USD) and Growth Rate (2013-2025)20
Table China Human Vaccine Sales (M Doses) of Key Players/Manufacturers (2017-2018)21
Table China Human Vaccine Sales Share (%) by Players/Manufacturers (2017-2018)21
Figure 2017 China Human Vaccine Sales Share (%) by Players/Manufacturers23
Figure 2018 China Human Vaccine Sales Share (%) by Players/Manufacturers24
Table China Human Vaccine Revenue (M USD) by Players/Manufacturers (2017-2018)24
Table China Human Vaccine Revenue Market Share (%) by Players/Manufacturers (2013-2018)25
Figure 2017 China Human Vaccine Revenue Market Share (%) by Players/Manufacturers26
Figure 2018 China Human Vaccine Revenue Market Share (%) by Players/Manufacturers27
Table China Market Human Vaccine Average Price (USD/Doses) of Key Players/Manufacturers (2013-2018)27
Figure China Market Human Vaccine Average Price of Key Players/Manufacturers in 201729
Figure 2017 China Human Vaccine Revenue Market Share (%) by Players/Manufacturers30
Figure China Human Vaccine Market Share of Top 5 Players/Manufacturers31
Figure China Human Vaccine Market Share of Top 10 Players/Manufacturers31
Table Mergers & Acquisitions, Expansion in China Market32
Table China Players/Manufacturers Human Vaccine Headquarters and Established Data35
Table China Human Vaccine Sales (M Dose) by Regions (2013-2018)36
Table China Human Vaccine Sales Share (%) by Regions (2013-2018)36
Figure China Human Vaccine Sales Share (%) by Regions (2013-2018)37
Figure China Human Vaccine Sales Market Share (%) by Regions in 201737
Table China Human Vaccine Revenue (M USD) and Market Share by Regions (2013-2018)38
Table China Human Vaccine Revenue Market Share (%) by Regions (2013-2018)38
Figure China Human Vaccine Revenue Market Share (%) by Regions (2013-2018)39
Figure China Human Vaccine Revenue Market Share (%) by Regions in 201739
Table China Human Vaccine Price (USD/Dose) by Regions (2013-2018)40
Table China Human Vaccine Sales (M Dose) by Type (2013-2018)41
Table China Human Vaccine Sales Share (%) by Type (2013-2018)41
Figure China Human Vaccine Sales Share (%) by Type (2013-2018)42
Figure China Human Vaccine Sales Market Share (%) by Type in 201743
Table China Human Vaccine Revenue (M USD) and Market Share by Type (2013-2018)43
Table China Human Vaccine Revenue Market Share (%) by Type (2013-2018)44
Figure Revenue Market Share of Human Vaccine by Type (2013-2018)45
Figure Revenue Market Share of Human Vaccine by Type in 201746
Table China Human Vaccine Price (USD/Dose) by Types (2013-2018)46
Figure China Human Vaccine Sales Growth Rate by Type (2013-2018)47
Table China Human Vaccine Sales (M Dose) by Applications (2013-2018)48
Table China Human Vaccine Sales Market Share (%) by Applications (2013-2018)48
Figure China Human Vaccine Sales Market Share (%) by Applications (2013-2018)49
Figure China Human Vaccine Sales Market Share (%) by Applications in 201749
Table China Human Vaccine Sales Growth Rate by Applications (2013-2018)50
Figure China Human Vaccine Sales Growth Rate (%) by Applications (2013-2018)50
Table CNBG Company Profile51
Figure Human Vaccine Product Picture of CNBG53
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of CNBG 2017-201853
Table Changsheng Life Company Profile54
Figure Human Vaccine Product Picture of Changsheng Life55
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Changsheng Life 2017-201855
Table Zhifei Company Profile55
Figure Human Vaccine Product Picture of Zhifei57
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Zhifei 2017-201857
Table ChengDa Bio Company Profile58
Figure Human Vaccine Product Picture of ChengDa Bio59
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of ChengDa Bio 2017-201859
Table Kangtai Company Profile59
Figure Human Vaccine Product Picture of Kangtai60
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Kangtai 2017-201861
Table SINOVAC BIOTECH Company Profile61
Figure Human Vaccine Product Picture of SINOVAC BIOTECH63
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of SINOVAC BIOTECH 2017-201863
Table Hissen Company Profile63
Figure Human Vaccine Product Picture of Hissen65
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Hissen 2017-201865
Table Walvax Biotechnology Company Profile65
Figure Human Vaccine Product Picture of Walvax Biotechnology67
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Walvax Biotechnology 2017-201867
Table GSK Company Profile68
Figure Human Vaccine Product Picture of GSK69
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of GSK 2017-201869
Table SANOFI Company Profile69
Figure Human Vaccine Product Picture of SANOFI71
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of SANOFI 2017-201871
Table Rong An Company Profile71
Figure Human Vaccine Product Picture of Rong An73
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Rong An 2017-201873
Table NuoCheng Bio Company Profile74
Figure Human Vaccine Product Picture of NuoCheng Bio75
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of NuoCheng Bio 2017-201875
Table Hualan Bio Company Profile76
Figure Human Vaccine Product Picture of Hualan Bio77
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Hualan Bio 2017-201878
Table Tiantan biological Company Profile78
Figure Human Vaccine Product Picture of Tiantan biological79
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Tiantan biological 2017-201879
Table Changchun Baike Company Profile80
Figure Human Vaccine Product Picture of Changchun Baike81
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Changchun Baike 2017-201881
Table Adimmune Company Profile82
Figure Human Vaccine Product Picture of Adimmune83
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Adimmune 2017-201883
Table Zhongyianke Biotech Company Profile84
Figure Human Vaccine Product Picture of Zhongyianke Biotech85
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Zhongyianke Biotech 2017-201885
Table Suppliers and Pictures of Raw Material86
Table Key Suppliers of Raw Materials87
Table Manufacturing Cost Structure of Human Vaccine89
Figure USA Labor Cost Analysis 2015-201890
Figure Cost of Employing a Factory Worker91
Figure Europe Labor Cost Analysis 2015-201892
Figure Germany Labor Cost Analysis 2015-201892
Figure UK Labor Cost Analysis 2015-201893
Figure France Labor Cost Analysis 2015-201893
Figure Italy Labor Cost Analysis 2015-201894
Figure Monthly Minimum Wages in Asia 201694
Figure China Labor Costs 2015-201895
Figure Japan Average Monthly Wages 2015-201895
Figure Global Electricity Prices by Select Countries in 2017 (in U.S. Dollars per Kilowatt Hour)96
Table Average Price of Electricity to Ultimate Customers 2007-201897
Figure Electricity Prices for Household Consumers in 201798
Table China Cost of Electricity 2017 (PER KWH)99
Figure Manufacturing Process Analysis of Human Vaccine101
Figure Human Vaccine Industrial Chain Analysis102
Table Major Buyers of Human Vaccine103
Figure Human Vaccine Chain Circulation System105
Figure Setting Pricing Policy107
Figure Global GDP Growth Rate for 2016112
Figure Real GDP Growth 2016-2020 annual Average113
Figure USA GDP 2008-2016 (Billion USD)114
Figure USA GDP Growth Rate Change 2015-2018114
Figure EU GDP 2008-2016 (Billion USD)115
Figure EU GDP Growth Rate Change 2015-2018115
Figure Germany GDP 2008-2016 (Billion USD)116
Figure Germany GDP Growth Rate 2015-2018116
Figure UK GDP 2008-2016 (Billion USD)116
Figure UK GDP Growth Rate 2015-2018117
Figure Italy GDP 2008-2016 (Billion USD)117
Figure Italy GDP Growth Rate 2015-2018117
Figure France GDP 2008-2016 (Billion USD)118
Figure France GDP Growth Rate 2015-2018118
Figure Japan GDP 2008-2016 (Billion USD)118
Figure Japan GDP Growth Rate 2015-2018119
Figure China GDP 2008-2016 (Billion USD)119
Figure China GDP Growth Rate 2015-2018119
Figure China Human Vaccine Sales (M Dose) and Growth Rate (%) Forecast (2019-2025)120
Figure China Human Vaccine Revenue (M USD) and Growth Rate Forecast (2019-2025)121
Table China Human Vaccine Sales (M Dose) Forecast by Type (2019-2025)121
Figure China Human Vaccine Sales ShareForecast by Type (2019-2025)122
Figure China Human Vaccine Sales Volume Market Share Forecast by Type in 2025123
Table China Human Vaccine Sales (M Dose) Forecast by Application (2019-2025)123
Figure China Human Vaccine Sales Volume Market Share Forecast by Application (2019-2025)124
Figure China Human Vaccine Sales Volume Market Share Forecast by Application in 2025125
Table China Human Vaccine Sales (M Dose) Forecast by Regions (2019-2025)125
Table China Human Vaccine Sales Volume Share Forecast by Regions (2019-2025)126
Figure China Human Vaccine Sales Volume Share Forecast by Regions (2019-2025)126
Figure China Human Vaccine Sales Volume Share Forecast by Regions in 2025127
Table Research Programs/Design for This Report129
Figure Bottom-up and Top-down Approaches for This Report131
Figure Data Triangulation132
Table Key Data Information from Secondary Sources133
Table Key Data Information from Primary Sources134

Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top